Posted inMarket
How to Protect a Loved One With Severe Mental Illness in Your Estate Plan
Learn essential estate planning strategies to protect a grandchild or relative with severe mental illness and secure their long-term financial future.
Posted inMarket
Diplomatic Efforts Advance as Leaders Discuss Potential Ukraine Peace Deal
Explore the latest updates on potential peace negotiations as international diplomats prepare for crucial visits to Moscow and Kyiv.
Posted inMarket
MPM BioVentures 2018 Disposes of Entrada Therapeutics Shares Worth $617k
Explore the recent financial transaction involving MPM BioVentures 2018 selling $617,000 worth of Entrada Therapeutics shares in the market.
Posted inMarket
eGain Q4 Financial Results Show Earnings Beat Alongside Revenue Shortfall
eGain released its latest financial report, revealing an earnings per share beat alongside a slight revenue miss compared to analyst expectations.
Posted inMarket
Vale Suspends Initial Public Offering Plans for Critical Minerals Division
Mining giant Vale has reportedly shelved plans to launch an initial public offering for its critical minerals business unit.
Posted inMarket
Japan Household Spending Declines for Eighth Consecutive Month in July
Japan household spending fell for the eighth straight month in July, highlighting ongoing economic pressures and consumer caution.
Posted inMarket
Ooma SVP Jenny Yeh Executes Stock Sale Worth Over 28000 Dollars
Discover recent insider trading updates as Ooma Senior Vice President Jenny Yeh sells company shares valued at over 28000 dollars.
Posted inMarket
Amalgamated Financial SEVP Sam Brown Sells Fractional Stock
Discover the latest insider trading update for Amalgamated Financial as SEVP Sam Brown executes a sale of fractional stock shares.
Posted inMarket
Ooma SVP Shuts Out Shares Worth Over 100000 Dollars in Recent Transaction
Discover the latest insider trading details regarding Ooma as a senior vice president sells over 107000 dollars in company shares.
Posted inMarket
MPM BioVentures Executes Significant Share Sale in Entrada Therapeutics
Discover the latest insider trading activity as major shareholder MPM BioVentures sells over six hundred thousand dollars in Entrada Therapeutics stock.
